the contribution of swog to bladder cancer clinical trials
Published 1 year ago • 298 plays • Length 18:16Download video MP4
Download video MP3
Similar videos
-
14:18
barriers to clinical trials for non-muscle invasive bladder cancer
-
15:17
the role of immunonutrition in bladder cancer & the simmune trial (s1600)
-
10:35
management of bcg unresponsive cystectomy ineligible bladder cancer patients pembrolizumab
-
13:23
updating the definitions, endpoints, and clinical trial designs for bladder cancer
-
11:21
bcg maintenance full swog course
-
9:40
industry perspective: the role of uro17 in the diagnosis and management of bladder cancer
-
20:52
bladder cancer and immunotherapy
-
5:06
va starport prostate cancer clinical trial
-
0:54
role of patient advocacy in clinical trial design
-
23:44
a review of aua/suo/astro guidelines for muscle invasive bladder cancer (mibc)
-
1:47
current and upcoming clinical trials in bladder cancer
-
16:25
new targets for advanced bladder cancer
-
20:29
neoadjuvant and adjuvant chemotherapy in bladder cancer
-
26:18
controversies in non-muscle invasive bladder cancer (nmibc): guidelines and beyond 2023
-
20:53
bcg unresponsive disease: a roadmap for drug development and novel therapies
-
17:42
bladder-sparing trimodality therapy
-
17:36
management of high-grade t1 bladder cancer
-
15:22
neoadjuvant immune checkpoint inhibition for muscle invasive bladder cancer